A randomised double-blind, double dummy trial to compare the efficacy and safety of Arimidex [anastrozole] with tamoxifen as first line therapy for advanced breast cancer in post-menopausal women
Latest Information Update: 12 Dec 2005
At a glance
- Drugs Anastrozole (Primary) ; Tamoxifen
- Indications Advanced breast cancer; Breast cancer
- Focus Registrational; Therapeutic Use
- Acronyms TARGET
- Sponsors AstraZeneca
- 12 Dec 2005 New trial record.